Stratipath is a spin-out from Karolinska Institutet that uses deep learning technology (AI) to provide risk profiling of cancer tumours. The company's cloud-based SaaS solutions are used in clinical settings and are based on cutting-edge research. Stratipath makes precision diagnostics available to more patients at a lower cost and in a fraction of the time compared to traditional methods. The company was founded in 2019.
Its founders include MedTechLabs researchers Mattias Rantalainen and Johan Hartman.